SignalXSignalX

COR Cencora

8-K Current Report
Filed: March 17, 2026
Consumer Staples
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora Overview

Cencora (COR) 8-K current report filed with SEC EDGAR on March 17, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 5.02: Departure/Election of Directors or Officers
  • Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

  • • CFO James F. Cleary retiring effective June 30, 2026 — planned transition, not a dispute-driven departure
  • • No successor named yet; CFO vacancy at a major pharma distributor (~$290B revenue) creates near-term leadership uncertainty
+1 more insights

Item 7.01 · Regulation FD Disclosure

  • • Boilerplate Reg FD disclosure only — no material financial data, guidance, or strategic information disclosed in the text itself
  • • Investors should look to the referenced Form 10-K for fiscal year ended September 30, 2025 for substantive financial details

Other Cencora 8-K Filings

8-K Mar 6, 2026

Get deeper insights on Cencora

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.